The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Pattern Recognition by TREM-2: Binding of Anionic Ligands
Abstract
We recently described the cloning of murine triggering receptor expressed by myeloid cells (TREM) 2, a single Ig domain DNAX adaptor protein 12-associated receptor expressed by cells of the myeloid lineage. In this study, we describe the identification of ligands for TREM-2 on both bacteria and mammalian cells. First, by using a TREM-2A/IgG1-Fc fusion protein, we demonstrate specific binding to a number of Gram-negative and Gram-positive bacteria and to yeast. Furthermore, we show that fluorescently labeled Escherichia coli and Staphylococcus aureus bind specifically to TREM-2-transfected cells. The binding of TREM-2A/Ig fusion protein to E. coli can be inhibited by the bacterial products LPS, lipoteichoic acid, and peptidoglycan. Additionally, binding can be inhibited by a number of other anionic carbohydrate molecules, including dextran sulfate, suggesting that ligand recognition is based partly on charge. Using a sensitive reporter assay, we demonstrate activation of a TREM-2A/CD3ζ chimeric receptor by both bacteria and dextran sulfate. Finally, we demonstrate binding of TREM-2A/Ig fusion to a series of human astrocytoma lines but not to a variety of other cell lines. The binding to astrocytomas, like binding to bacteria, is inhibited by anionic bacterial products, suggesting either a similar charge-based ligand recognition method or overlapping binding sites for recognition of self- and pathogen-expressed ligands.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Sequence variants of the LPS-receptor TLR4 [84] and the LPS-binding receptor TREM2 [22] are also associated with an increased risk of AD, indicating additional genetic links between AD and endotoxin.”
From The endotoxin hypothesis of neurodegeneration (2019) · cites this paper as [22]
Citations
Cites
Giard, D. J., Aaronson, S. A., Todaro, G. J., Arnstein, P., Kersey, J. H., Dosik, H., & Parks, W. P. (1973) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/51.5.1417 · Cited by 2,336
HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C
Braud, V. M., Allan, D., O'Callaghan, C. A., Söderström, K., D’Andrea, A., Ogg, G. S., Lazetic, S., Young, N. T., Bell, J. I., Phillips, J. H., et al. (1998) · Nature · doi:10.1038/35869 · Cited by 2,226
Bouchon, A., Dietrich, J., & Colonna, M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.10.4991 · Cited by 1,284 · cited 11×
“Three members of the mouse TREM family have been studied: TREM-1 (1, 4), TREM-2 (3, 5), and TREM-3 (2).”
BackgroundMethodInfluentialDirect Recognition of Cytomegalovirus by Activating and Inhibitory NK Cell Receptors
Arase, H., Mocarski, E. S., Campbell, A. E., Hill, A. B., & Lanier, L. L. (2002) · Science · doi:10.1126/science.1070884 · Cited by 1,229
Gordon, S. (2002) · Cell · doi:10.1016/s0092-8674(02)01201-1 · Cited by 1,185
TREM-1 amplifies inflammation and is a crucial mediator of septic shock
Bouchon, A., Facchetti, F., Weigand, M. A., & Colonna, M. (2001) · Nature · doi:10.1038/35074114 · Cited by 1,092
Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells
Mandelboim, O., Lieberman, N., Lev, M., Paul, L., Arnon, T. I., Bushkin, Y., Davis, D. M., Strominger, J. L., Yewdell, J. W., & Porgador, A. (2001) · Nature · doi:10.1038/35059110 · Cited by 990
MHC class I alloantigen specificity of Ly-49+ IL-2-activated natural killer cells
Karlhofer, F. M., Ribaudo, R. K., & Yokoyama, W. M. (1992) · Nature · doi:10.1038/358066a0 · Cited by 803
Colonna, M., & Samaridis, J. (1995) · Science · doi:10.1126/science.7716543 · Cited by 736
Paloneva, J., Manninen, T., Christman, G., Hovanes, K., Mandelin, J., Adolfsson, R., Bianchin, M., Bird, T., Miranda, R., Salmaggi, A., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/342259 · Cited by 683
Research works printed but not linked: 42
- 2000, J. Immunol., 4991
- 2002, Eur. J. Immunol, 59
- 2001, Eur. J. Immunol., 783
- 2001, Nature, 1103
- 2001, J. Exp. Med., 1111
- 2002, Blood, 3822
- 1999, J. Immunol., 2472
- 2002, Am. J. Hum.Genet., 656
- 2000, Nat. Genet., 357
- 2003, J. Clin. Invest., 323
- 2000, Immunity, 355
- 2000, Immunity, 345
- 1994, Int. Immunol., 369
- 1987, Acta Neuropathol., 92
- 1978, Med. Biol., 184
- 1973, J. Natl. Cancer Inst., 1417
- 2002, Curr. Opin. Immunol., 123
- 2002, J. Neurochem., 1309
- 2003, Eur. J. Immunol., 567
- 2002, Cell, 927
- 1998, J. Biol. Chem., 19592
- 2002, Biochem. Biophys. Res. Commun., 1462
- 2002, Acta Crystallogr. D, 1843
- 2001, Eur. J. Immunol., 2680
- 1995, Science, 405
- 1995, Immunity, 439
- 1997, Nature, 181
- 1994, J. Immunol., 1068
- 1993, Annu. Rev. Immunol, 613
- 1997, J. Immunol., 3603
- 1995, Immunity, 801
- 1992, Nature, 66
- 1998, Nature, 795
- 1998, J. Exp. Med., 1841
- 1999, J. Biol. Chem., 559
- 1999, J. Exp. Med., 1801
- 1999, J. Exp. Med., 493
- 2002, Science, 1323
- 2001, Nature, 1055
- 2002, J. Immunol., 3451
- 2000, J. Neuroimmunol., 220
- 2003, Structure, 1
Cited by
Sorted by citations
Items 201–291 of 291
Lafuse, W. P., Alvarez, G. R., Curry, H. M., & Zwilling, B. S. (2006) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2006.26.548 · Cited by 16
The lipid-sensor TREM2 aggravates disease in a model of LCMV-induced hepatitis
Kosack, L., Gawish, R., Lercher, A., Vilagos, B., Hladik, A., Lakovits, K., Bhattacharya, A., Schliehe, C., Mesteri, I., Knapp, S., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-10637-y · Cited by 15
Role of TREM2 in the Development of Neurodegenerative Diseases After Traumatic Brain Injury
Zhang, C., & Chen, S. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-03094-w · Cited by 14
TREM-2: friend or foe in infectious diseases?
Matos, A. D. O., Dantas, P. H. D. S., Queiroz, H. A. G. D. B., Silva‐Sales, M., & Sales‐Campos, H. (2022) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2022.2146481 · Cited by 12
TREM-2 Drives Development of Multiple Sclerosis by Promoting Pathogenic Th17 Polarization
Qu, S., Hu, S., Xu, H., Wu, Y., Ming, S., Zhan, X., Wang, C., & Huang, X. (2023) · Neuroscience Bulletin · doi:10.1007/s12264-023-01094-x · Cited by 14
Peña‐Ortega, F. (2016) · Current Neuropharmacology · doi:10.2174/1570159x14666160928151546 · Cited by 14
Pumo, A., & Legeay, S. (2024) · Brain Research · doi:10.1016/j.brainres.2024.148817 · Cited by 14
Arsenault, R., Marshall, S., Salois, P., Li, Q., & Zhang, W. (2024) · Biology · doi:10.3390/biology13020087 · Cited by 11
RhoA/ROCK/GSK3β Signaling: A Keystone in Understanding Alzheimer’s Disease
Medd, M. M., Yon, J. E., & Dong, H. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47020124 · Cited by 11
Bandow, K., Hasegawa, H., Tomomura, M., & Tomomura, A. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.01.045 · Cited by 11
TREM2 in Regulating Macrophage Inflammatory Responses and Disease Pathogenesis
Medd, M. M. (2024) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.2024054889 · Cited by 12
Alí‐Ruiz, D., Vitureira, N., & Peluffo, H. (2023) · Scientific Reports · doi:10.1038/s41598-023-43840-1 · Cited by 8
Xu, J., Gao, F., Liu, Y.-A., Zhang, X., Chen, H., Zhu, X., Song, H., Qian, F., Li, M., Yang, C. G., et al. (2018) · Clinical and Experimental Medicine · doi:10.1007/s10238-018-0534-1 · Cited by 9
Characterization of bovine cDNA encoding triggering receptor expressed on myeloid cells 1 (TREM-1)
Ramanathan, B., Minton, J. E., Ross, C. R., & Blecha, F. (2004) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2004.05.007 · Cited by 9
Liao, Y., Mu, G., Deng, S., Lu, B. F., & Zheng, M. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-07604-x · Cited by 8
Bandow, K., Smith, A., & Garlick, J. A. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.10.048 · Cited by 8
Emerging non-proinflammatory roles of microglia in healthy and diseased brains
Sun, Y., Che, J., & Zhang, J. (2023) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2023.110664 · Cited by 10
Unveiling the impact of TREM-2+ Macrophages in metabolic disorders
Contreras, M., Matos, A. D. O., Dantas, P. H. D. S., Neto, J. R. D. C., Silva‐Sales, M., & Sales‐Campos, H. (2024) · Cellular Immunology · doi:10.1016/j.cellimm.2024.104882 · Cited by 10
Microglia: A CNS-Specific Tissue Macrophage
Puntambekar, S. S., Doose, J. M., & Carson, M. J. (2007) · Springer eBooks · doi:10.1007/978-0-387-73894-9_1 · Cited by 8
Zhou, X., Liu, Z., Li, S., Song, Y., Sun, M., Si, Z., & Zhu, W. (2025) · Inflammation Research · doi:10.1007/s00011-025-02155-9 · Cited by 7
Crosstalk between peripheral immunity and central nervous system in Alzheimer’s disease
Yang, H.-C., Qin, Q., Wang, M., Yin, Y., Li, R., & Tang, Y. (2023) · Cellular Immunology · doi:10.1016/j.cellimm.2023.104743 · Cited by 9
Building a potent TREM2 agonistic, biparatopic, common light chain antibody
Almeida, A. R., Geddie, M. L., Bhate, A., Quan, C., Arndt, J. W., Jiao, Y., Santoro, J. C., Noiman, L., Vijayakumar, R., Sanchez-Salazar, J., et al. (2025) · mAbs · doi:10.1080/19420862.2025.2546554 · Cited by 8
Synergistic potential of TREM2 agonists and exercise training in Alzheimer’s disease
Zhang, J., Schneider, B. A., Muguerza, E., Chung, E. K., & Hsu, C. G. (2026) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00124.2025 · Cited by 6
Worthmann, A., & Heeren, J. (2020) · Immunometabolism · doi:10.20900/immunometab20200014 · Cited by 5
Fabrication of an Oriented Fc‐Fused Lectin Microarray through Boronate Formation
Chen, M., Adak, A. K., Yeh, N., Yang, W., Chuang, Y., Wong, C., Hwang, K., Hwu, J. R., Hsieh, S., & Lin, C. (2008) · Angewandte Chemie · doi:10.1002/ange.200803377 · Cited by 6
Akinluyi, E. T., Takahashi, K., Connolly, M. G., Poon, W. W., & Macauley, M. S. (2025) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5c00805 · Cited by 5
TREM2 as a Therapeutic Target in Atherosclerosis
Xu, S., Yang, B., Yu, W., Gao, Y., Cai, H., & Wang, Z. (2025) · Cell Biology International · doi:10.1002/cbin.12279 · Cited by 7
Jendresen, C., Daws, M. R., & Nilsson, L. N. G. (2017) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2017.11.004 · Cited by 5
Self-citationSek, A. C., Percopo, C. M., Boddapati, A. K., Ma, M., Geslewitz, W. E., Krumholz, J. O., Lack, J., & Rosenberg, H. F. (2021) · Journal of Leukocyte Biology · doi:10.1002/jlb.3a0920-620r · Cited by 5
Protein recognition is chiefly mediated by the CDR2 region in TREM2 - an in silico characterization
Dantas, P. H. D. S., Matos, A. D. O., Colmenares, M. T. C., Costa, V. A. F., Felice, A. G., Neto, J. R. D. C., Soares, S. D. C., Silva‐Sales, M., Neves, B. J., & Sales‐Campos, H. (2025) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2025.109058 · Cited by 4
Toledano‐Díaz, A., Álvarez, M. I., & Tolédano, A. (2022) · Journal of Central Nervous System Disease · doi:10.1177/11795735221123896 · Cited by 5
Nucleosides accelerate inflammatory osteolysis, acting as distinct innate immune activators
Pan, G., Zheng, R., Yang, P., Li, Y., Clancy, J. P., Liu, J., Feng, X., Garber, D. A., Spearman, P. W., & McDonald, J. M. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.400 · Cited by 4
Revelo, X. S., Fredrickson, G., Florczak, K. L., Barrow, F., DIETSCHE, K. B., Wang, H., Parthiban, P., Almutlaq, R. N., Adeyi, O. A., Herman, A., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-3446960/v1 · Cited by 4
Fuchs, N. S., Kuncewicz, K., Gaamouch, F. E., & Gabr, M. T. (2025) · SLAS DISCOVERY · doi:10.1016/j.slasd.2025.100255 · Cited by 4
Quipildor, G. F., Belfiore, R., Althobaiti, K., Najarzadeh, Z., Glabe, C. C., Readhead, B. P., Gandy, S., Salton, S. R., & Ehrlich, M. E. (2026) · Molecular Neurodegeneration Advances · doi:10.1186/s44477-025-00012-x · Cited by 6
Alterations in the brain lipidome of Alzheimer's disease donors with rare TREM2 risk variants
Proitsi, P., Ebshiana, A., Wretlind, A., Xu, J., Hodges, A., & Legido‐Quigley, C. (2026) · Brain Communications · doi:10.1093/braincomms/fcaf452 · Cited by 3
Exploring the orphan immune receptor TREM2 and its non-protein ligands: In silico characterization
Dantas, P. H. D. S., Costa, V. A. F., Felice, A. G., Sousa, E. G., Matos, A. D. O., Soares, S. D. C., Silva‐Sales, M., Neves, B. J., & Sales‐Campos, H. (2024) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2024.105449 · Cited by 3
sTREM2 in the prognostic evaluation of acute lung injury after cardiac surgery in infants
Yang, L., Sun, M., Ying, L., Liu, X., Zhao, W., Lin, R., & Shu, Q. (2023) · Pediatric Research · doi:10.1038/s41390-023-02915-5 · Cited by 3
Mishra, S., Rout, M., Simha, N. L., Dehury, B., & Pati, S. (2024) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2024.126281 · Cited by 3
Sayed, F. A., Kodama, L., Udeochu, J. C., Fan, L., Carling, G. K., Le, D., Li, Q., Zhou, L., Mathys, H., Wang, M., et al. (2020) · doi:10.1101/2020.07.24.218719 · Cited by 3
The flexible stalk domain of sTREM2 modulates its interactions with brain-based phospholipidsPreprint
Saeb, D., Lietzke, E. E., Fuchs, D. I., Aldrich, E. C., Bruce, K. D., & Sprenger, K. G. (2024) · eLife · doi:10.7554/elife.102269 · Cited by 4
Zhong, Z., Ulmschneider, M. B., & Lorenz, C. D. (2025) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5c01891 · Cited by 2
Anto, L., Gao, L., Lee, J., Garcia, C., Otoko, O., Hickey, E., Mishra, N., Kim, S., Noh, S. G., Kim, M., et al. (2026) · Gastro Hep Advances · doi:10.1016/j.gastha.2026.101064 · Cited by 2
TRAPC : A novel Triggering Receptor expressed on Antigen Presenting Cells
van der Holst, R. (2007) · Figshare · Cited by 2
Amir, A., Shahid, M., Khan, S. F., Nisar, U., Faizi, S., & Sımjee, S. U. (2023) · Brain Research · doi:10.1016/j.brainres.2023.148686 · Cited by 1
Small molecules as ligands in the tuning of immune regulatory receptors
Fioretto, L., Ziaco, M., Nuzzo, G., Albiani, F., Saponaro, M., Carbone, D., Barra, G., dell’Isola, M., Follero, O., Esercizio, N., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1648691 · Cited by 1
Pottorf, T. S., Lane, E. L., & Álvarez, F. J. (2025) · Cells · doi:10.3390/cells14191520 · Cited by 1
Kim, D., Kondo, T., & Inoue, H. (2026) · Stem Cell Reports · doi:10.1016/j.stemcr.2026.102866 · Cited by 1
Takahashi, K. (2018) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12479 · Cited by 1
Ikezu, T. (2016) · Springer eBooks · doi:10.1007/978-3-319-44022-4_16 · Cited by 1
Ikezu, T. (2016) · Springer eBooks · doi:10.1007/978-3-319-44022-4_30 · Cited by 1
sTREM-1 as a severity marker in patients with septic shock with abdominal surgery
Pedro, C.-P. J., Patricia, B. C., García-León, M. L., Arturo, C.-S. J., Baltazar‐López, N., Rafael, Z. R. F., Angel-Ambrocio, A. H., & Wong‐Chew, R. M. (2020) · Journal of Anesthesia & Critical Care Open Access · doi:10.15406/jaccoa.2020.12.00459 · Cited by 1
Investigation of the role of a large serine rich repeat protein in Streptococcus pneumoniae
Saville, A. M. (2009) · Enlighten: Theses (The University of Glasgow) · Cited by 1
Stangassinger, M. (2008) · Cited by 1
Iizasa, E., Chuma, Y., Uematsu, T., Kubota, M., Kawaguchi, H., Umemura, M., Toyonaga, K., Kiyohara, H., Yano, I., Colonna, M., et al. (2020) · doi:10.21203/rs.3.rs-37581/v1 · Cited by 1
Carbajosa, G., Malki, K., Lawless, N., Wang, H., Ryder, J. W., Wozniak, E., Wood, K., Mein, C. A., Hodgkinson, A., Dobson, R., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.07.16.452732 · Cited by 1
Sphingosine 1-phosphate, a Novel TREM2 Ligand, Promotes Phagocytosis and Reduce Ischemic InjuryPreprint
Sun, X., Xue, T.-F., Ji, J., Guo, R., Sun, Y., Wang, X., Guo, W., Cai, Z., Huang, X.-X., Yang, J., et al. (2020) · Research Square · doi:10.21203/rs.3.rs-114600/v1 · Cited by 1
Gallo, C., Manzo, E., Barra, G., Fioretto, L., Ziaco, M., Nuzzo, G., d’Ippolito, G., Ferrera, F., Contini, P., Castiglia, D., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1211312/v1 · Cited by 1
Trem2 deficiency does not worsen metabolic function in diet-induced obese micePreprint
Winn, N. C., Wolf, E. M., Garcia, J. N., & Hasty, A. H. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.06.13.495953 · Cited by 1
The flexible stalk domain of sTREM2 modulates its interactions with phospholipids in the brainPreprint
Saeb, D., Lietzke, E. E., Fuchs, D. I., Aldrich, E. C., Bruce, K. D., & Sprenger, K. G. (2024) · eLife · doi:10.7554/elife.102269.1 · Cited by 1
TREM-2 expression and regulation in inflammation and ischaemia
Bradley, J. (2014) · UEA Digital Repository (University of East Anglia)
Cloning and characterization of a novel inhibitory receptor expressed by myeloid cells
Errico, D. Á. (2006) · Repositori digital de la UPF (Universitat Pompeu Fabra)
Die immunregulatorischen Trigger-Rezeptoren auf myeloiden Zellen (TREM) beim Haushuhn
Hanczaruk, M. A. (2008) · Elektronische Hochschulschriften der LMU München (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.8869
Virulence of Salmonella enterica serovar typhimurium and innate antibacterial host responses
Bjur, E. (2006) · Figshare
Kiialainen, A. (2007) · STM:n Hallinnonalan avoin julkaisuarkisto (Julkari)
Signal Inhibitory Receptor on Leukocytes-1 (SIRL-1), a potent regulator of neutrophil function
Avondt, K. V. (2014) · Utrecht University Repository (Utrecht University)
Functional characterization of the CD300e leukocyte receptor
Brckalo, T. (2011) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
МехАнИзМЫ УпРАвленИя МИгРАцИей МИелОИднЫх дендРИтнЫх Клет ОК И Клет ОК лАнгеРг Анс А
Yu, T. V., & Cells, L. (2012) · CyberLeninK (CyberLeninka)
Regulation of Toll-like Receptor Signal Transduction Pathways
Lu, Y. (2009) · TSpace (University of Toronto)
Defining microglial phenotypic diversity and the impact of ageing
Grabert, K. (2015) · ERA
Mewes-Arès, J. (2010) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3gs85
Intraspinal Delivery of Recombinant AAV-Mediated Interleukin-10 Modifies Disease in ALS Mice
Chakrabarty, P., & Ayers, J. I. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809813-4.00011-9
Myelin, cPLA2, and Azithromycin
Kopper, T. J. (2021) · UKnowledge (University of Kentucky) · doi:10.13023/etd.2021.381
Fredrickson, G., Florczak, K. L., Barrow, F., DIETSCHE, K. B., Wang, H., Parthiban, P., Almutlaq, R. N., Adeyi, O. A., Herman, A., Bartolomucci, A., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.06.11.544503
Hanotte, J. L. (2023) · El Servicio de Difusión de la Creación Intelectual (National University of La Plata) · doi:10.35537/10915/161150
Ikezu, T. (2024) · Springer eBooks · doi:10.1007/978-3-031-68237-7_22
Zhong, Z., Ulmschneider, M. B., & Lorenz, C. D. (2025) · bioRxiv · doi:10.1101/2025.06.26.661739
The flexible stalk domain of sTREM2 modulates its interactions with brain-based phospholipidsPreprint
Saeb, D., Lietzke, E. E., Fuchs, D. I., Aldrich, E. C., Bruce, K. D., & Sprenger, K. G. (2025) · eLife · doi:10.7554/elife.102269.2
The TREMS: A Multifaceted Family of Immunoreceptors
Gibot, S., & Lévy, B. (2005) · Springer eBooks · doi:10.1007/0-387-26272-5_33
Vautheny, A. (2019) · theses.fr (ABES) · doi:10.70675/1812d71aze8d9z48d6z87d1z5a23a4e81953
Han, D., Kim, N. H., Han, S.-Y., 송혜은, Cho, S. B., Cha, S. Y., 백예찬, Kim, K., Kim, S., Kim, H., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.19.719526
Yook, J. I., Han, D., Kim, N. H., Han, S.-Y., 송혜은, Cho, S. B., Cha, S. Y., 백예찬, Kime, K., Kim, S., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-9466880/v1
TREM2 drives monocyte-derived macrophage responses to Cryptococcus neoformansPreprint
Abass, A., Ricafrente, A., Trivedi, A., Vichaidit, A., Arshakyan, A., Acharya, S., & Heung, L. J. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.10.731331
Lietzke, E. E., Saeb, D., Aldrich, E. C., de Menezes, R. F., Bruce, K. D., & Sprenger, K. G. (2026) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2026.06.002 · Cited by 1
Wang, H., Wen, R., Parker, E., & Yang, L. (2026) · Cell Communication and Signaling · doi:10.1186/s12964-026-03083-9 · Cited by 2
Yang, G., Xu, X., & Xu, Y. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1893545
Dynamic Crosstalk Between TREM2+ Macrophages and the MASLD Hepatic Microenvironment
Li, X., Yu, C., Mao, A., Peng, Y., Yiyang, H., & Zhao, Y. (2026) · Biomedicines · doi:10.3390/biomedicines14102167
Metadata
- Authors
- Daws, M. R., Sullam, P. M., Niemi, E. C., Chen, T. T., Tchao, N. K., & Seaman, W. E.
- Affiliations
- San Francisco VA Medical Center (US)
- Department of Immunology, Veterans Affairs Medical Center and University of California , San Francisco
- University of California, San Francisco (US)
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-07
- Volume
- 171
- Issue
- 2
- Pages
- 594-599
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2101372125
- Cited by
- 291
- References
- 44
- Citations by year
- 2026: 12 · 2025: 17 · 2024: 14 · 2023: 17 · 2022: 20 · 2021: 17 · 2020: 20 · 2019: 11 · 2018: 21 · 2017: 16 · 2016: 11 · 2015: 15 · 2014: 12 · 2013: 9 · 2012: 7
- FWCI
- 3.25
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Veterans Affairs
- National Cancer Institute (R01CA087922, R01 CA87922-01A1)
- National Institute of Allergy and Infectious Diseases (AI41513, R01AI041513)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Immunology and Microbiology › Immunology › Inflammation biomarkers and pathways
- Life Sciences › Immunology and Microbiology › Immunology › Phagocytosis and Immune Regulation
- Keywords
- TREM2, pattern recognition, myeloid cells, Gram-negative bacteria, Gram-positive bacteria, Escherichia coli, Staphylococcus aureus, yeast, lipopolysaccharide, lipoteichoic acid, peptidoglycan, dextran sulfate, astrocytoma, innate immunity, receptor activation
- MeSH terms
- Animals, Anions, Astrocytoma, Bacterial Adhesion, Binding, Competitive, Gram-Negative Bacteria, Gram-Positive Bacteria, Humans, Immunoglobulin Fc Fragments, Leukemia P388, Ligands, Lipopolysaccharides, Peptidoglycan, Protein Binding, Receptors, Immunologic, Recombinant Fusion Proteins, Solubility, Teichoic Acids, Transfection, Tumor Cells, Cultured, Dextran Sulfate, Jurkat Cells, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review